These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 38865340

  • 21. Cerebrospinal Fluid and Plasma Biomarkers do not Differ in the Presenile and Late-Onset Behavioral Variants of Frontotemporal Dementia.
    Marelli C, Hourregue C, Gutierrez LA, Paquet C, Menjot de Champfleur N, De Verbizier D, Jacob M, Dubois J, Maleska AM, Hirtz C, Navucet S, Bennys K, Dumurgier J, Cognat E, Berr C, Magnin E, Lehmann S, Gabelle A.
    J Alzheimers Dis; 2020; 74(3):903-911. PubMed ID: 32083577
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy.
    Illán-Gala I, Montal V, Borrego-Écija S, Vilaplana E, Pegueroles J, Alcolea D, Sánchez-Saudinós B, Clarimón J, Turón-Sans J, Bargalló N, González-Ortiz S, Rosen HJ, Gorno-Tempini ML, Miller BL, Lladó A, Rojas-García R, Blesa R, Sánchez-Valle R, Lleó A, Fortea J, Catalan Frontotemporal Dementia Initiative (CATFI) and the Frontotemporal Lobar Degeneration Neuroimaging Initiative (FTLDNI).
    Brain; 2019 Apr 01; 142(4):1121-1133. PubMed ID: 30906945
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia.
    Paraskevas GP, Kasselimis D, Kourtidou E, Constantinides V, Bougea A, Potagas C, Evdokimidis I, Kapaki E.
    J Alzheimers Dis; 2017 Apr 01; 55(4):1453-1461. PubMed ID: 27858708
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update.
    Oeckl P, Steinacker P, Feneberg E, Otto M.
    J Neurochem; 2016 Aug 01; 138 Suppl 1():184-92. PubMed ID: 27186717
    [Abstract] [Full Text] [Related]

  • 32. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.
    Rohrer JD, Woollacott IO, Dick KM, Brotherhood E, Gordon E, Fellows A, Toombs J, Druyeh R, Cardoso MJ, Ourselin S, Nicholas JM, Norgren N, Mead S, Andreasson U, Blennow K, Schott JM, Fox NC, Warren JD, Zetterberg H.
    Neurology; 2016 Sep 27; 87(13):1329-36. PubMed ID: 27581216
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia.
    Mesulam MM, Weintraub S, Rogalski EJ, Wieneke C, Geula C, Bigio EH.
    Brain; 2014 Apr 27; 137(Pt 4):1176-92. PubMed ID: 24574501
    [Abstract] [Full Text] [Related]

  • 36. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
    Bieniek KF, Murray ME, Rutherford NJ, Castanedes-Casey M, DeJesus-Hernandez M, Liesinger AM, Baker MC, Boylan KB, Rademakers R, Dickson DW.
    Acta Neuropathol; 2013 Feb 27; 125(2):289-302. PubMed ID: 23053135
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.